Loading...
Given the investor's beginner level, long-term strategy, and available investment capital, Angi Inc. is not a strong buy at this time. The technical indicators show bearish trends, options data reflects a lack of bullish sentiment, and the company's financial performance has been poor with declining revenue and net income. Analyst sentiment is mixed to negative, and there are no recent positive catalysts or news to suggest an imminent turnaround. A hold is recommended until stronger signs of recovery or growth are evident.
The technical indicators for ANGI are bearish. The MACD is below 0 and negatively contracting, RSI is neutral at 26.206, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at 7.791 and resistance at 8.891.

The company's gross margin increased by 5.20% YoY in Q4 2025, which is a positive sign for operational efficiency.
Analysts have lowered price targets and expressed concerns about delayed revenue growth. No recent news or significant trading trends from hedge funds, insiders, or Congress.
In Q4 2025, Angi Inc. reported a revenue decline to $240.77M (-10.12% YoY), a net income drop to $7.22M (-661.74% YoY), and an EPS decrease to 0.17 (-666.67% YoY). However, gross margin improved to 90.87% (+5.20% YoY).
Analysts have lowered price targets significantly, with RBC Capital reducing to $12 from $18, KeyBanc to $11 from $17, UBS to $11 from $15, Benchmark to $20 from $27, and Truist to $17 from $23. Ratings range from Neutral to Buy, but sentiment reflects skepticism due to delayed revenue growth and disappointing guidance.